Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johannes A Bogaards

Showing results (1-10 of 90) with videos related to

Pageof 9
Sort By:
Future Oncology (London, England)|December 15, 2010
Vaccination against human papillomavirus types 16 and 18: the impact on cervical cancerJohannes Berkhof, Johannes A Bogaards
The Journal of Antimicrobial Chemotherapy|October 18, 2003
Meeting the immense need for HAART in resource-poor settingsJohannes A Bogaards, Jaap Goudsmit
The Lancet. Infectious Diseases|November 26, 2011
Assessment of herd immunity from human papillomavirus vaccinationJohannes A Bogaards, Johannes Berkhof
BMC Medicine|June 8, 2025
Projected health and economic effects of nonavalent versus bivalent human papillomavirus vaccination in preadolescence in the NetherlandsBirgit Sollie, Johannes Berkhof, Johannes A Bogaards
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|July 28, 2018
Pricing of HPV vaccines in European tender-based settingsVenetia Qendri, Johannes A Bogaards, Johannes Berkhof
Epidemiology (Cambridge, Mass.)|June 21, 2018
Inferring Pathogen Type Interactions Using Cross-sectional Prevalence Data: Opportunities and Pitfalls for Predicting Type ReplacementIrene Man, Jacco Wallinga, Johannes A Bogaards
The Journal of Infectious Diseases|June 7, 2017
Health and Economic Impact of a Tender-Based, Sex-Neutral Human Papillomavirus 16/18 Vaccination Program in the NetherlandsVenetia Qendri, Johannes A Bogaards, Johannes Berkhof
JNCI Cancer Spectrum|July 31, 2019
Who Will Benefit From Expanding HPV Vaccination Programs to Boys?Venetia Qendri, Johannes A Bogaards, Johannes Berkhof
JHEP Reports : Innovation in Hepatology|April 5, 2026
Reply - Letter to the Editor "Unaddressed concerns of potential follow up bias in the International PSC Registry"Bregje Mol, Johannes A Bogaards, Cyriel Y Ponsioen
International Journal of Cancer|January 29, 2026
Cost-effectiveness analysis of human papillomavirus (HPV) genotyping strategies for management of HPV-positive women in cervical cancer screeningKelsi R Kroon, Johannes A Bogaards, Johannes Berkhof
Pageof 9

Showing results (1-10 of 90) with videos related to

Sort By:
Pageof 9
Future Oncology (London, England)|December 15, 2010
Vaccination against human papillomavirus types 16 and 18: the impact on cervical cancerJohannes Berkhof, Johannes A Bogaards
The Journal of Antimicrobial Chemotherapy|October 18, 2003
Meeting the immense need for HAART in resource-poor settingsJohannes A Bogaards, Jaap Goudsmit
The Lancet. Infectious Diseases|November 26, 2011
Assessment of herd immunity from human papillomavirus vaccinationJohannes A Bogaards, Johannes Berkhof
BMC Medicine|June 8, 2025
Projected health and economic effects of nonavalent versus bivalent human papillomavirus vaccination in preadolescence in the NetherlandsBirgit Sollie, Johannes Berkhof, Johannes A Bogaards
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|July 28, 2018
Pricing of HPV vaccines in European tender-based settingsVenetia Qendri, Johannes A Bogaards, Johannes Berkhof
Epidemiology (Cambridge, Mass.)|June 21, 2018
Inferring Pathogen Type Interactions Using Cross-sectional Prevalence Data: Opportunities and Pitfalls for Predicting Type ReplacementIrene Man, Jacco Wallinga, Johannes A Bogaards
The Journal of Infectious Diseases|June 7, 2017
Health and Economic Impact of a Tender-Based, Sex-Neutral Human Papillomavirus 16/18 Vaccination Program in the NetherlandsVenetia Qendri, Johannes A Bogaards, Johannes Berkhof
JNCI Cancer Spectrum|July 31, 2019
Who Will Benefit From Expanding HPV Vaccination Programs to Boys?Venetia Qendri, Johannes A Bogaards, Johannes Berkhof
JHEP Reports : Innovation in Hepatology|April 5, 2026
Reply - Letter to the Editor "Unaddressed concerns of potential follow up bias in the International PSC Registry"Bregje Mol, Johannes A Bogaards, Cyriel Y Ponsioen
International Journal of Cancer|January 29, 2026
Cost-effectiveness analysis of human papillomavirus (HPV) genotyping strategies for management of HPV-positive women in cervical cancer screeningKelsi R Kroon, Johannes A Bogaards, Johannes Berkhof
Pageof 9